ONE Bio Signs Japanese Distribution Agreement With Sanyo
02 March 2011 - 12:00AM
Marketwired
ONE Bio, Corp. ("ONE" or the "Company") (OTCBB: ONBI), an
innovative company utilizing green process manufacturing to produce
raw chemicals and herbal extracts, natural and health supplements
and organic products, today announced that it has signed a
distribution agreement with Sanyo Trading Co. Ltd. ("Sanyo"), one
of the largest international trading companies in Japan. The
agreement further expands ONE's distribution network in Japan.
Under the terms of the agreement, ONE will produce a new
private-label line of organic products for distribution to Sanyo's
network of supermarket chains, which ranges from large, moderately
priced chains such as Jusco, Ito Yokado, Seiyu (owned by Wal-Mart)
and Daiei to smaller neighborhood food shops including Foodex, Y's
Mart, and Ogikubo.
The new contract follows the success of ONE's private-label
brand for Kobe Bussan, a leading Japanese supermarket operator.
Since launching the private-label line in March 2010, ONE's Organic
Products ("OP") division has achieved 20% sales growth in Japan.
Japan currently accounts for over 30% of the OP division's sales,
with the strong consumer demand for its products fueled by the high
quality-control standards utilized by the Company in its organic
vegetable selection and manufacturing processes. ONE's organic
vegetable products are Japanese Agricultural Standard ("JAS")
Gold-certified, the highest certification for organic products in
Japan.
"Japan continues to be our strongest export market. The Japanese
market for organic food and drinks is the largest in the
Asia-Pacific region, and Japanese consumers benefit from the
highest disposable income in Asia. Our rapid market acceptance in
Japan strongly reflects the quality and safety of our products. We
appreciate the confidence Kobe, Sanyo and other Japanese retailers
have entrusted to us," stated ONE's CEO, Marius Silvasan.
Mr. Silvasan continued, "According to Datamonitor, the global
organic food market grew by 9.7 percent in 2009 to reach $60
billion. It is anticipated that by 2014, this market could reach
$96.6 billion in value, an increase of 60.7 percent from 2009. We
are committed to aggressively adding distribution channels to take
advantage of this rapidly growing global demand."
About ONE Bio, Corp. ONE Bio, Corp.
("ONE") (OTCBB: ONBI) (www.onehcorp.com), headquartered in Miami,
FL, is an innovative company utilizing patented green process
manufacturing to produce raw chemicals and herbal extracts, natural
supplements and organic products. ONE is focused on the
Asia-Pacific region and the United States. Key products include
widely recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic
fertilizers, and organic bamboo health food and beverages. ONE has
experienced solid organic growth driven by a robust demand for its
products in China, Japan and the United States.
About Sanyo Trading Co. Ltd. Sanyo Trading
was established in 1947 in Japan. The Company employs over 200
employees and has a turnover volume of $286 million Euro. Sanyo
Trading is headquartered in Tokyo with offices in Osaka and Nagoya,
and international offices in New York, Detroit, Cincinnati,
Vancouver, Tianjin, Shanghai, Shenzhen, Bangkok, Melbourne, Hanoi,
Ho Chi Minh City, and Maastricht, Netherlands.
This press release includes statements that constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE
Bio, Corp. claims the protection of the safe-harbor for
forward-looking statements contained in the Reform Act. These
forward-looking statements are often characterized by the terms
"may," "believes," "projects," "expects," or "anticipates," and do
not reflect historical facts. Specific forward-looking statements
contained in this press release include, but are not limited to:
our successful integration of diversified growth companies, impact
of the company's expansion plan, and new business development
success, future financial results, development and acquisition of
new product lines and services, the impact of competitive products
or pricing from technological changes, the effect of economic
conditions and other uncertainties. The forward-looking statements
contained herein involve risks and uncertainties that could cause
actual results to differ materially from the expectations contained
in any such forward-looking statements. These risks include, but
are not limited to: failure to manage operating expenses or
integrate new companies and/or technologies, each of which could
have a material impact on our business, our financial results, and
the company's stock price. These risks and other factors are
detailed in the Company's regular filings with the U.S. Securities
and Exchange Commission. Most of these factors are difficult to
predict accurately and are generally beyond the Company's control.
Forward-looking statements speak only as to the date they are made
and ONE Bio, Corp. does not undertake to update forward-looking
statements to reflect circumstances or events that occur after the
date the forward-looking statements are made.
Company Contact: Jeanne Chan Senior VP Tel. +888.676.4445
jchan@onehcorp.com Investor Relations Contact: Investor Relations
& Corporate Communications 888-676-4445 ir@onehcorp.com Dave
Gentry U.S. RedChip Companies, Inc. Tel: +1-800-733-2447, Ext. 104
Email: info@redchip.com Jing Zhang China RedChip Beijing
Representative Office Tel: +86 10-8591-0635 Web:
http://www.RedChip.com
One Bio (CE) (USOTC:ONBI)
Historical Stock Chart
From Jun 2024 to Jul 2024
One Bio (CE) (USOTC:ONBI)
Historical Stock Chart
From Jul 2023 to Jul 2024